Family Office Briefing on research bySavills·Jul 12, 2025
The Life Sciences Tenant Q2 2025
Life sciences markets face supply-demand imbalance in Q2 2025 — family offices should consider co-GP opportunities with strategic operators.
Life ScienceQ2 2025
Key Metrics
| Metric | Value |
|---|---|
| National VC Funding | 20.8billion |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Savills
Building a thesis around Life Science? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.